Century Therapeutics, Inc. (IPSC) Insider Trading

Over the last 3 months, IPSC insiders made 0 open-market buys and 5 sales, a net sale of -$12K (SEC Form 4). Over the last 6 months, 27 institutions increased and 28 reduced their position (13F).

Insider Activity

Sentiment
0/100
Buys (3m)
0
Sells (3m)
5
Net (3m)
-$11.7K
Insider trades by month Buys Sells
Nov
Dec
Feb
Mar
May
Jun
Context3-month price +8.4%Institutions accumulating (13F)
DateInsiderTypeSharesPrice
Jun 15, 2026Cowan Chadofficer: Chief Scientific OfficerTax358$2.24
Jun 15, 2026Russotti Gregoryofficer: See RemarksSell2,584$2.23
Jun 15, 2026Carr Douglasofficer: SVP Finance & OperationsSell1,654$2.23
Jun 15, 2026Pfeiffenberger Brentdirector, officer: President and CEOTax13,849$2.24
Jun 12, 2026Lee Han MyungdirectorGrant74,000$2.24
Jun 12, 2026Riva AlessandrodirectorGrant74,000$2.24
Jun 12, 2026Quimi DaphnedirectorGrant74,000$2.24
Jun 12, 2026Murphy Martin PatrickdirectorGrant74,000$2.24
Jun 12, 2026Blackwell KimberlydirectorGrant74,000$2.24
Jun 9, 2026Pfeiffenberger Brentdirector, officer: President and CEOTax463$2.13
Jun 9, 2026Carr Douglasofficer: SVP Finance & OperationsSell249$2.11
Jun 9, 2026Russotti Gregoryofficer: See RemarksSell524$2.11
May 19, 2026Pfeiffenberger Brentdirector, officer: President and CEOTax31,172$2.34
May 6, 2026Carr Douglasofficer: SVP Finance & OperationsSell264$2.34
Apr 10, 2026Murphy Martin PatrickdirectorGrant88,000$0.59
Apr 3, 2026Cowan Chadofficer: Chief Scientific OfficerTax1,365$2.19
Mar 16, 2026Russotti Gregoryofficer: See RemarksSell10,076$2.55
Mar 16, 2026Carr Douglasofficer: SVP Finance & OperationsSell7,043$2.55
Mar 13, 2026Pfeiffenberger Brentdirector, officer: President and CEOTax55,397$2.73
Mar 13, 2026Cowan Chadofficer: Chief Scientific OfficerTax1,431$2.73
Mar 11, 2026Russotti Gregoryofficer: See RemarksSell479$2.54
Mar 10, 2026Pfeiffenberger Brentdirector, officer: President and CEOTax463$2.56
Feb 18, 2026Pfeiffenberger Brentdirector, officer: President and CEOTax31,172$1.75
Feb 5, 2026Carr Douglasofficer: SVP Finance & OperationsSell323$1.82
Feb 4, 2026Pfeiffenberger Brentdirector, officer: President and CEOGrant475,000
Feb 4, 2026Russotti Gregoryofficer: See RemarksGrant265,000$1.84
Feb 4, 2026Russotti Gregoryofficer: See RemarksGrant135,000
Feb 4, 2026Pfeiffenberger Brentdirector, officer: President and CEOGrant945,000$1.84
Feb 4, 2026Carr Douglasofficer: SVP Finance & OperationsGrant225,000$1.84
Feb 4, 2026Cowan Chadofficer: Chief Scientific OfficerGrant265,000$1.84

Source: IPSC SEC Form 4 filings, latest Jun 15, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their IPSC positions over the last 6 months (SEC Form 13F).

Increased
27
New positions
39
Reduced
28
Sold out
18
Largest moves
InstitutionActionSharesFiled
RA CAPITAL MANAGEMENT, L.P.New Position17.8MMay 15, 2026
TCG CROSSOVER MANAGEMENT, LLCNew Position17.8MMay 15, 2026
VERSANT VENTURE MANAGEMENT, LLCNew Position12.2MMay 5, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position11.4MMay 15, 2026
DEEP TRACK CAPITAL, LPNew Position9.5MMay 15, 2026
RTW INVESTMENTS, LPNew Position8.7MMay 15, 2026
VR ADVISER, LLCNew Position8.7MMay 15, 2026
COMMODORE CAPITAL LPNew Position8.7MMay 15, 2026
WOODLINE PARTNERS LPNew Position6.1MMay 15, 2026
POINT72 ASSET MANAGEMENT, L.P.Increased6.0MMay 15, 2026
POINT72 ASSET MANAGEMENT, L.P.New Position6.0MFeb 17, 2026
Seven Fleet Capital Management LPNew Position5.9MJun 4, 2026
BALYASNY ASSET MANAGEMENT L.P.New Position5.0MMay 15, 2026
MILLENNIUM MANAGEMENT LLCIncreased4.7MMay 15, 2026
Spruce Street Capital LPIncreased4.1MMay 14, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.